创新医疗：签署参股公司全诊医学《B+轮增资协议》《B+轮股东协议》及相关文件

Group 1 - The core point of the news is that QuanZhen Medical is undergoing a B+ round financing to support its business development, with investments from multiple partners [1] - The company has agreed to sign the B+ round capital increase agreement and shareholder agreement with the investors [1] - After the capital increase and share transfer, the company's stake will be 16.5160% [1] Group 2 - According to the B+ round capital increase agreement, Puhua Zhongxiao will invest RMB 20 million, subscribing to an increase in registered capital of RMB 1.180579 million [2] - Changzhou Hengnuo and the Talent Fund will each invest RMB 5 million, subscribing to an increase in registered capital of RMB 0.295145 million [2] - Following the capital increase, the registered capital of QuanZhen Medical will rise to RMB 165.28106 million, with Puhua Zhongxiao, Changzhou Hengnuo, and the Talent Fund acquiring 7.1429%, 1.7857%, and 1.7857% equity respectively [2]